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Abstract Similarity of compound chemical structures
often leads to close pharmacological proﬁles, including
binding to the same protein targets. The opposite, however,
is not always true, as distinct chemical scaffolds can
exhibit similar pharmacology as well. Therefore, relying on
chemical similarity to known binders in search for novel
chemicals targeting the same protein artiﬁcially narrows
down the results and makes lead hopping impossible. In
this study we attempt to design a compound similarity/
distance measure that better captures structural aspects of
their pharmacology and molecular interactions. The mea-
sure is based on our recently published method for com-
pound spatial alignment with atomic property ﬁelds as a
generalized 3D pharmacophoric potential. We optimized
contributions of different atomic properties for better dis-
crimination of compound pairs with the same pharmacol-
ogy from those with different pharmacology using Partial
Least Squares regression. Our proposed similarity measure
was then tested for its ability to discriminate pharmaco-
logically similar pairs from decoys on a large diverse
dataset of 115 protein–ligand complexes. Compared to 2D
Tanimoto and Shape Tanimoto approaches, our new
approach led to improvement in the area under the receiver
operating characteristic curve values in 66 and 58% of
domains respectively. The improvement was particularly
high for the previously problematic cases (weak perfor-
mance of the 2D Tanimoto and Shape Tanimoto measures)
with original AUC values below 0.8. In fact for these cases
we obtained improvement in 86% of domains compare to
2D Tanimoto measure and 85% compare to Shape Tan-
imoto measure. The proposed spatial chemical distance
measure can be used in virtual ligand screening.
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Introduction
Ligand-based approaches to protein family proﬁling has
been widely studied and used for in silico pharmacology
[1]. Similarity of compound chemical structures often leads
to close pharmacological proﬁles, including binding to the
same protein targets. By this reason, chemical similarity
criterion is widely used for identiﬁcation of novel lead
molecules in the development of pharmaceuticals. A vari-
ety of chemical similar measures has been proposed.
However, in many cases compounds with similar phar-
macology escape correct recognition as they appear to be
dissimilar by any existing measure.
In order to navigate in ligand space, one need to rep-
resent the compound using appropriate properties
(descriptors) and then use a master equation to measure a
distance between two compounds.
Descriptors are usually classiﬁed according to their
dimensionality ranging from one-dimensional (1-D) to
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to compute 1-D descriptors describe global properties
which can be derived from chemical formula and classify
compounds or ligands from various target families [3–5,
10]. To perform fast comparison 1-D linear representations
of compounds are often used. The most popular of this kind
of simpliﬁed string is the ‘Simpliﬁed Molecular Input Line
Entry System’ or SMILES [3, 6, 10].
To improve discrimination, 2D topological descriptors
are used. Graph-based methods, such as maximum com-
mon subgraph (MCS) [3, 7, 10] and ﬁngerprint-based
methods [3, 8, 10] are popular for substructure clustering
chemical compounds into subfamilies. Subgraph isomor-
phism in large molecular databases is quite often time
consuming to perform on large numbers of structures and it
was for this reason that substructure screening was devel-
oped as a rapid method of ﬁltering out those molecules that
deﬁnitely do not contain the substructure of interest [10,
46]. The similarity between two molecules represented by
2D binary ﬁngerprints is most frequently quantiﬁed using
the Tanimoto coefﬁcient, which gives a measure of the
number of fragments in common between the two mole-
cules [3, 9, 10].
It is well known that molecular recognition depends on
the 3D structure and properties of molecule rather than the
underlying substructure(s) [10]. 3D methods are computa-
tionally more expensive than 2D descriptor based methods,
because they require consideration of conformational space
of the molecule. These methods can be divided into
methods that are alignment-independent and methods that
require the molecules to be aligned in 3D space before
similarity function is used [10].
Some computationally expensive alignment-indepen-
dent methods use 3D geometrical descriptors represent
them in a binary ﬁngerprint and then use with the Tanimoto
coefﬁcient exactly as for 2D ﬁngerprints [10, 11]. Other
methods are 3D equivalent of the MCS [10, 12, 13]. Many
3D approaches are based on the use of distances matrices
where the value of each element (i, j) equals the inter-
atomic distance between atoms i and j [10, 14]. Also there
are approaches where the pharmacophore points are used
for similarity comparisons [10, 15–17].
Consideration of conformational ﬂexibility of the mol-
ecules as well as their relative orientation is required for
alignment dependent methods [10]. These methods devised
to align the compared structures via maximization of the
similarity function that is used [10, 45]. Many different
ways have been developed to represent molecules and
calculate similarity based on molecular shape and/or ﬁeld
[18–31, 45]. For reviews of molecular similarity methods,
see refs [2, 10, 32–36].
The aim of this study is to design a spatial distance
measure between two chemicals that optimizes recognition
of their pharmacological similarity by using their 3D
conformational ensembles and properties pertaining to
molecular interactions. We recently introduced a novel
spatial alignment method based on atomic property ﬁelds
(APF) as a generalized 3D pharmacophoric potential [37].
APF is the representation of the ligand by a multi-com-
ponent (vector) 3D potential, with the components corre-
sponding to various physico-chemical atomic properties. In
the present study, the APF alignment is used to measure
spatial chemical similarity/distance between ligands.
A diverse benchmark of 99 proteins (see Supplementary
Table 1 for details) and ligands co-crystallized with these
proteins (with 6 ligands per protein on average) was used to
train APF parameters for better discrimination of pharma-
cologically similar pairs from dissimilar ones. All possible
combinations of pairs of ligands from the same receptors as
well as for ligands co-crystallized with certain protein all
possible combinations of pairs with ligands co-crystallized
with 20 different randomly chosen from benchmark other
proteins, were taken and APF representation of larger
ligand was used as a reference to superimpose them. Dis-
tances between all superimposed pairs of ligands have been
evaluated. Performance and results of proposed approach
are reported and systematically compared to those obtained
with standard 2D ﬁngerprints (using 2D Tanimoto equation
[38]) and 3D shape (using shape Tanimoto similarity
measure [38]) based approaches (see Supplementary
Table 2 for details).
Materials and methods
Atomic property ﬁeld
Atomic property ﬁeld (APF) [37] is the representation of
the ligand by multi-component (vector) 3D grid potential
Pi (r ~), with the components i corresponding to various
physico-chemical properties. Each property component of
the APF determines whether the presence at any speciﬁc
point r ~in space of an atom with that particular property is
favorable or unfavorable. Pseudo-energy (score) of an atom
j in this ﬁeld is a dot product of its property vector /
j
i and
the APF potential at its position r ~
j:
EAPF ¼ 
X
i
/
j
iPiðr ~
jÞ: ð1Þ
The minima for this pseudo-energy for an atom with any
speciﬁc property vector /
j
i will be in the areas of space
with similar APF potential components.
Assignment of property vectors /
j
i for various atom
types is carried out as described in [37], according to the
general knowledge of their empiric physico-chemical
behavior. Seven property ﬁeld components were introduced:
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2 hybrid-
ized, lipophilic, size, charged, and electronegative/electro-
positive.Fiveofthem(hydrogenbonddonor,hydrogenbond
acceptor, sp
2 hybridized, lipophilic and charged) are classic
pharmacophoric types. Other two (size and electronegative/
electropositive) are extension to make APF vectors differ-
entiate certain atom types that are indistinguishable by the
ﬁrst ﬁve components: for example, aliphatic carbon (as in a
methyl group) and large halogens are differentiated by
electronegativity. For more details, see [37].
APF-based local ligand superimposition
Suboptimal ligand superimpositions were obtained for all
pairs of compounds binding to the same protein by
superimposing the protein binding pockets. These subop-
timal superimpositions were improved by locally mini-
mizing APF-correspondence between the two ligands. APF
representation was generated from the larger ligand. The
second ligand was ﬂexibly minimized in the obtained ﬁeld
in a search for the local minimum of its APF-score cal-
culated as described above. The local minimization pro-
cedure used the Newton method [39] if the number free
variables of a given molecule are less than 100 and swit-
ched to the conjugate gradient method [39] if number
of free variables exceeded 100. The maximal number of
function evaluations was set to N
2, where N is number of
free variables of a molecule. This local minimization pro-
cedure is implemented in the ICM software [40].
APF-based global ligand superimposition
For all ligand pairs that do not bind to the same protein,
global ligand superimposition was performed by Monte
Carlo search of the minimum of the APF-score of the
smaller ligand in the APF of the larger. Similarly, the
maximal number of function evaluations was set to N
2,
where N is number of free variables of a given molecule.
The global minimization procedure is implemented in the
ICM software [40].
Dataset of protein–ligand complexes
The proposed approach to similarity measure was validated
on a comprehensive benchmark of protein–ligand com-
plexes from RCSB Protein Data Bank with high resolution
and drug-like ligands (Kufareva et al. manuscript in prep-
aration). For this validation, all ligands were paired up with
one another to form the so-called correct and decoy pairs.
A pair of ligands was considered correct if these ligands
exhibited similar pharmacology exempliﬁed by binding to
the same protein target, as found in PDB. If two ligands
were not found in co-crystal complexes with any single
protein, they formed an incorrect,o rdecoy pair. As the
number of decoy pairs was several order of magnitude
larger than the number of correct pairs, we compressed the
decoy set by pairing each ligand up with all ligands from
20 randomly chosen proteins (rather than all other pro-
teins), excluding the cognate receptor.
The dataset was randomly split into a training set and a
test set. The training set consisted of 2,538 correct and
9,819 decoy pairs, so that their numbers are in the same
order of magnitude. The test set consisted of 1898 correct
and 317,807 decoy pairs. For the training data set, correct
ligand pairs were superimposed locally starting from their
crystallographic poses as described above, while the decoy
pairs were superimposed globally. For the test set all pairs
were superimposed using global APF superimposition
described above.
Partial least square regression
Partial least square (PLS) regression [41, 42] was used to
design the proposed similarity measure. PLS is a recent
technique that generalizes and combines features from
principal component analysis and multiple regression. The
purpose of PLS is to approximate a dependent (target)
variable Y with a linear combination of independent vari-
ables Xi (descriptors). The output of the learning algorithm
then consists of a linear coefﬁcient ci for each of the
descriptors Xi and a free term c0.
For each ligand pair in the training set, we assigned the
value of Y equal to 1 for correct pairs and 0 for decoy pairs.
PLS regression was trained to approximate these values as
a linear combination of the seven descriptors
E
2;i
APF
.
E
1;i
APF ði ¼ 1;...;7Þ: The optimal vector of coefﬁ-
cients, ci, was used to access pairwise similarity if the
compounds in the test set. The relative contributions wi of
seven descriptors, further referred as weights, were evalu-
ated as ci
.P7
i¼1 ci. A recent implementation of PLS in
ICM software [40] was used.
Design of novel spatial chemical distance measure
To design a novel and optimal spatial chemical distance
measure we undertook the following approach (see Fig. 1).
For each ligand pair, we performed the following steps.
First, the larger ligand (greater number of heavy atoms)
was locally relaxed from its bioactive conformation in its
receptor and its APF representation was built. Second, the
smaller ligand was ﬂexibly superimposed onto the larger
ligand using local and global APF-based superimposition
for correct and decoy pairs, respectively. Third, the pseudo-
energies, E
1;i
APF and E
2;i
APF ði ¼ 1;...;7Þ; of the larger and
the smaller ligands in the APF potential grid of the larger
ligand were calculated.
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2;i
APF
.
E
1;i
APF ði ¼ 1; ...;7Þ;
were recorded as descriptors of the ligand pair, and PLS
regression was trained to approximate the correct/decoy
(1/0) value as a weighted sum
X 7
i¼1
wi
E
2;i
APF
E
1;i
APF
: ð2Þ
The protocol is built on top of a well established and
implemented in ICM APF concept and ICM gradient
minimization.
The weights wi (i = 1, …,7) obtained by the PLS
regression were used in the deﬁnition of the compound
chemical distance as:
D12 ¼ 1  
X 7
i¼1
wi
E
2;i
APF
E
1;i
APF
: ð3Þ
2D tanimoto distance calculation
Compounds chemical similarity was evaluated as Tanim-
oto distance between their molecular ﬁngerprints as
implemented in ICM [40]. Brieﬂy, given a molecule, all
linear and non-linear fragments of different size were
enumerated and hashed into a bit string called a ﬁngerprint.
The Tanimoto coefﬁcient, T, for two ﬁngerprints was cal-
culated as the number of bits in which they differ divided
Fig. 1 Schematic outline of approach to design a novel spatial chemical distance measure
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Tanimoto distance was deﬁned as 1 - T.
3D shape tanimoto distances
For each compound, the volume of its molecular envelope
was calculated using ICM. For every pair of compounds
superimposed by the APF-based algorithm, the volume of
the smallest envelope enclosing both compounds, V, was
calculated. The overlapping volume, V12, was found by
V12 = V1 ? V2 - V. The 3D shape Tanimoto distance [38]
between the two compounds was calculated as
3DShapeTanimotoDistance ¼ 1  
V12
V
; ð4Þ
where V12 is the volume overlap between two compounds,
V1 and V2 are volumes of compounds.
Distance distribution analysis
Distance probability distribution curves were built by
normalization (division by number of observations) of
histogram plots of 2D Tanimoto, 3D Shape Tanimoto, and
our newly designed distances for all correct and decoy
pairs from the test set. Global discrimination abilities of 2D
Tanimoto, 3D Shape Tanimoto, and our newly designed
distance measure are evaluated by calculating an overlap-
ping area between distance probability distribution curves
for all correct and decoy pairs from the test set.
ROC AUC values
The new measure was evaluated for its ability to distin-
guish correct compound pairs from decoy pairs on the large
test set. The performance of the measure was evaluated as
the area under the ROC (receiver operating characteristic)
curve, or ROC AUC. ROC curve analysis [43] describes
the ability of a screening method to avoid false positives
and false negatives. The ideal screening device demon-
strates the ROC AUC value of 1, while a random selection
performance corresponds to the ROC AUC value of 0.5.
ROC AUC analysis was performed for 2D Tanimoto,
3D Shape Tanimoto, and our newly designed chemical
distance measure for the entire test set. Also ROC AUC
analysis was performed for 2D Tanimoto, 3D Shape Tan-
imoto, and our newly designed chemical distance measure
for each of the 115 protein ensembles in the testing set.
Statistical analysis
To evaluate the statistical signiﬁcance of the obtained ROC
AUC values, we assumed that they are distributed
according to Gaussian distribution with mean 0.5. The
uncertainty r is calculated by performing 20 random sta-
tistical experiments in which the ranks are reshufﬂed,
calculating individual ROC AUCs and calculating the root
mean square deviation of those ROC AUCs. For each ROC
AUC values obtained on a given subset of correct and
decoy pairs, its P-value was calculated as probability to
obtain the same AUC by random coincidence:
P-value ¼ 1  
1
2
1 þ erf
ROCAUCvalue   0:5
r
ﬃﬃﬃ
2
p
     
; ð5Þ
where erf is the error function [44] and r is the standard
deviation. Small P-values below 0.05 mean high statistical
signiﬁcance, while cases with large P-values are statisti-
cally less signiﬁcant.
Software and hardware
Ligand preparation, superimpositions, APF generations,
evaluation of pseudo-energies and PLS regression analysis
were carried out with ICM 3.6 (Molsoft LLC, La Jolla,
CA).
The hardware facility employed in the present study was
Intel Core 2 Duo workstation (2.4 GHz with 2 GB of RAM
memory).
Results and discussion
APF-based compounds chemical distance measure
In this study, we propose an algorithm for evaluation of
compound spatial chemical distance that consists of ﬁve
consecutivesteps(Fig. 2):(1)theligandwithgreaternumber
of heavy atoms is locally relaxed from its bioactive coordi-
nates (found in the co-crystal structure with its target pro-
tein); (2) APF potential grid maps are built from this ligand;
(3) the smaller ligand is ﬂexibly superimposed onto the lar-
ger ligand by minimizing its APF-score in the ﬁeld of the
larger ligand; (4) ratios E
2;i
APF
.
E
1;i
APF ði ¼ 1;...;7Þ are cal-
culated, where E
1;i
APF are the pseudo-energies of the larger
ligandinitsownAPFmapsandE
2;i
APF arethepseudo-energies
ofthesmallerligandinAPFrepresentationofthelargerone;
(5) the similarity score is calculated by (2) and the chemical
distance between the compounds is found by (3).
The weights wi in Eq. (2) were derived by Partial Least
Squares regression optimizing the pairwise correct/decoy
(1/0) discrimination value as a linear combination of the
E
2;i
APF
.
E
1;i
APF ði ¼ 1;...;7Þ ratios as described in ‘‘Mate-
rials and Methods’’. The results of regression are shown in
the Table 1. The APF potential component corresponding
to the atomic size was found to contribute the most to the
compound similarity. This result indicates the fact that
shape complementarity between compounds has a
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123fundamental role, so that compounds with similar shape
often have similar pharmacological proﬁles.
According to these results, the spatial chemical distance
between two compounds can be measured by
D12 ¼ 1  
 
0:15
E
2;1
APF
E
1;1
APF
þ 0:14
E
2;2
APF
E
1;2
APF
þ 0:02
E
2;3
APF
E
1;3
APF
þ 0:24
E
2;4
APF
E
1;4
APF
þ 0:3
E
2;5
APF
E
1;5
APF
þ 0:01
E
2;6
APF
E
1;6
APF
þ 0:12
E
2;7
APF
E
1;7
APF
 
:
ð6Þ
Screening performance of novel spatial chemical
distance measure
The screening performance ofthe proposed spatialchemical
distancemeasurewastestedonthediversesetof1898correct
(from 115 proteins) and 317,807 decoy pairs (see Supple-
mentaryTable 2).Globaldiscriminationabilitiesofdifferent
methods used in this studyare presented inthe Fig. 3.In this
plot, the relative frequencies of three types of compound
distances are shown for correct and decoy compound pairs.
Asexpected,thedistributionpeaksareshiftedwithrespectto
each other in all three cases, reﬂecting the fact that on aver-
age,compoundsincorrectpairstendtobeclosertoeachother
than compounds in decoy pairs. However, it is clear that the
newly proposed chemical distance measure provides better
separation of the peaks than either 2D ﬁngerprint Tanimoto
distance or 3D shape Tanimoto distance. Indeed, by our new
measure,only52%ofthecorrectpairsappearinthedistance
region of decoy pairs (Fig. 3c). The corresponding number
forthe other two distance measuresappear tobe 64 and 56%
(Fig. 3a, b). Discrimination abilities of different methods
used in this study also can be seen in the Fig. 4, where ROC
curves and overall correct/decoy discrimination ROC AUC
values for the test set are presented. Our new proposed
chemicaldistancemeasuregivesROCAUCvalueof0.81,in
contrast to 0.79 and 0.74 obtained by using 3D shape Tan-
imoto distance and 2D ﬁngerprint Tanimoto distance. These
results clearly shows an advantage of our new approach in
lead/decoydiscriminationonthebenchmarkcomparedto2D
Tanimoto and 3D Shape Tanimoto approaches.
It also can be seen in the Fig. 5 where the performance
of the proposed measure was individually evaluated for
each of the 115 protein targets from the test set. By using
the novel spatial compounds chemical distance measure,
the correct/decoy discrimination ROC AUC value was
improved for 66% of the test set when compared to 2D
Tanimoto, and 58% when compared to 3D Shape Tanim-
oto. The improvement was particularly high for the pre-
viously problematic cases (weak performance of the 2D
Tanimoto and Shape Tanimoto measures) with original
AUC values below 0.8. For these cases we obtained
Fig. 2 Schematic ﬂowchart of calculation of spatial chemical
distance between two compounds
Table 1 Relative and absolute contribution of components of APF
potential to spatial chemical distance measure
Components of APF potential Relative
contribution wi (%)
Coefﬁcient ci
Hydrogen bond donor 15 0.5
Hydrogen bond acceptor 14 0.46
sp
2 hybridization 2 0.035
Lipophilicity 24 0.73
Size 30 -0.86
Charge 1 0.01
Electronegativity 12 0.37
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123improvement in 86% of domains compared to 2D Tanim-
oto measure and 85% compared to 3D Shape Tanimoto
measure. The average ROC AUC value improvement for
these cases equals 0.12 and 0.24 with standard deviation
0.15 and 0.24, respectively (Fig. 5a, b).
Compared to 2D Tanimoto approach, the best
improvement (up to 0.92 in AUC units) was achieved for
compounds with perfectly matching pharmacophores but
no common substructure. An example is given in the
Fig. 6, where the two ligands were taken from Geranyl-
transtransferase and globally superimposed as described
above. The newly proposed distance measure returns the
value of 0.28 for these two compounds, in contrast to 0.88
obtained by 2D Tanimoto measure. Consequently, using
our measure for correct/decoy discrimination for this pro-
tein resulted in the ROC AUC value of 0.99, in contrast to
0.07 obtained by 2D Tanimoto approach. As another
extreme, there are cases where 2D Tanimoto approach
provides better recognition (Fig. 5a, AUCs based on 2D
Tanimoto distance greater than 0.8). In general these are
the cases where the two compounds have a common sub-
structure but other parts of them are signiﬁcantly different.
However, even in these cases, our new approach performs
reasonably accurate and provides systematically high
AUCs with 0.85 on average and 0.11 standard deviation.
Thereisnodoubtthatligandshape,anditscomplimentary
totheshapeoftheproteininteractionsiteareoffundamental
importance for their bioactivity. However, comparison of
ligandsbyshapecausescompoundsofdissimilardimensions
to be down-ranked during virtual screening. Such ligands,
however,mayhavehighafﬁnitytoatargetastheymayform
additional interactions with the protein. The results pre-
sented in the Fig. 5b), namely up to 0.54 improvement in
AUC, show that our new spatial chemical distance measure
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ranked by the 3D-shape based measure.
Conclusions
In this study, we developed a spatial chemical distance
measure between two chemicals by using their 3D
conformational ensembles and properties pertaining to
molecular interactions. The parameters for our novel mea-
sure were obtained by training a PLS regression to distin-
guish the correct ligand pairs from decoys on a large and
sufﬁciently diverse set of correct pairs of ligands, which
were taken from the same receptor and decoy pairs of
ligands, which were taken from different receptors. The
screening performance of the proposed spatial chemical
distance measure was tested on a diverse and pharmaceu-
tically relevant test set of correct and decoy pairs. Com-
pared to 2D Tanimoto and Shape Tanimoto approaches, our
new approach led to improvement in the area under the
receiver operating characteristiccurve values in 66 and 58%
of domains respectively. The improvement was particularly
high for the previously problematic cases (weak perfor-
mance of the 2D Tanimoto and Shape Tanimoto measures)
with original AUC values below 0.8. In fact for these cases
we obtained improvement in 86% of domains compare to
2D Tanimoto measure and 85% compare to Shape Tanim-
oto measure.
The presented results suggest that our new spatial
chemical distance measure can be successfully used in
virtual ligand screening for novel chemical scaffolds tar-
geting the existing proteins of therapeutic relevance.
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(a) and Shape Tanimoto (b) measures. Each dot represents one
domain. The dots are colored in different colors spread evenly among
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Fig. 6 Indicative example of weak performance of approach based
on 2D Tanimoto similarity measure: a 2D structures of two ligands,
which have taken from Geranyltranstransferase; b same ligands in
their bioactive conformations; c ligands superimposed by approach
suggested in this study. According to 2D Tanimoto similarity
measure, distance between these two compounds equals 0.88, in
contrast to measure introduced here, which gives distance 0.28. For
this particular protein AUC based on 2D Tanimoto approach equals
0.07, in contrast to 0.99, obtained based on our new approach
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